Submission strategy and filing calendar
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
PharmaRevix supports new applications, variations, renewals, annual reports, eCTD publishing, and MAH-related regulatory operations across key markets.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Confirm submission route and required dossier components
Compile and publish the application package
Manage authority validation and review questions
Transition into lifecycle maintenance after approval
The work is designed for real review: authority questions, partner due diligence, quality audits, and internal leadership updates.
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
PharmaRevix supports Module 1-5 compilation, baseline conversion, sequence management, validation, and submission-ready publishing across modern eCTD toolchains.
Explore serviceFrom scientific advice to pre-submission meetings, PharmaRevix helps teams prepare the agenda, briefing package, Q&A strategy, and post-meeting follow-up.
Explore servicePharmaRevix supports PI and DMF translation, label and artwork preparation, mock-up review, and lifecycle artwork management across regional requirements.
Explore serviceShort answers for teams deciding whether this is the right next step.
Ask us anythingTalk with PharmaRevix about scope, timelines, and the cleanest next step for your market or safety obligation.